SNN Stock Overview
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Smith & Nephew plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£25.31 |
52 Week High | UK£32.29 |
52 Week Low | UK£21.53 |
Beta | 0.57 |
1 Month Change | -2.99% |
3 Month Change | -6.02% |
1 Year Change | -21.30% |
3 Year Change | -41.29% |
5 Year Change | -42.25% |
Change since IPO | 206.79% |
Recent News & Updates
Recent updates
Smith & Nephew: Work To Be Done But Still Long-Term Potential
Jun 12Smith & Nephew: Orthopedics Growth Continues To Drive Sales Forward
Dec 28Smith & Nephew Getting More Interesting As A Contrarian Idea
Oct 12Smith & Nephew: Entering New Markets But Growth Is Slow Still
Aug 01Smith & Nephew reports FY earnings; initiates FY23 guidance
Feb 21Smith & Nephew: Potential Only Has Value If You Can Execute
Dec 14Smith & Nephew: Still A Buy Despite Short-Term Challenges
Sep 26Smith & Nephew 1H 2022 Earnings Preview
Jul 27Smith+Nephew launches app Wound Compass to help reduce variation in wound care
Jul 12Smith & Nephew: Fair Price For An Attractive Medical Devices Supplier
Jun 01Smith & Nephew: Valuation Looking More Attractive
Jan 26Smith & Nephew Is A Premium Brand That Should Deliver Something Special
Nov 06Smith & Nephew Leveraged To Post-Pandemic Normalization And Self-Help
Sep 02Smith & Nephew plc: Improving Performance Reflected In Price
Jun 18Smith & Nephew: Pandemic Long Tail Reduces Attractiveness
Jan 14Smith & Nephew: A Long-Term Buy And Hold In Medical Devices
Nov 09Shareholder Returns
SNN | US Medical Equipment | US Market | |
---|---|---|---|
7D | -3.2% | -1.1% | 1.0% |
1Y | -21.3% | -0.9% | 20.8% |
Return vs Industry: SNN underperformed the US Medical Equipment industry which returned -0.9% over the past year.
Return vs Market: SNN underperformed the US Market which returned 20.8% over the past year.
Price Volatility
SNN volatility | |
---|---|
SNN Average Weekly Movement | 3.2% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 5.7% |
10% most volatile stocks in US Market | 15.4% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SNN has not had significant price volatility in the past 3 months.
Volatility Over Time: SNN's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1856 | 18,452 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
SNN fundamental statistics | |
---|---|
Market cap | US$11.06b |
Earnings (TTM) | US$263.00m |
Revenue (TTM) | US$5.55b |
42.1x
P/E Ratio2.0x
P/S RatioIs SNN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SNN income statement (TTM) | |
---|---|
Revenue | US$5.55b |
Cost of Revenue | US$1.66b |
Gross Profit | US$3.89b |
Other Expenses | US$3.63b |
Earnings | US$263.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 01, 2024
Earnings per share (EPS) | 0.30 |
Gross Margin | 70.14% |
Net Profit Margin | 4.74% |
Debt/Equity Ratio | 55.3% |
How did SNN perform over the long term?
See historical performance and comparison